1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Interval from onset to treatment*
Combined (n = 16) IV rtPA (n = 13) P Value Onset To emergency department 52 ± 12 47 ± 25 .50 To CT scan 60 ± 13 57 ± 28 .67 To IV rtPA 110 ± 22 118 ± 37 .47 To intra-arterial rtPA 150 ± 25 − To termination of thrombolysis 213 ± 49 178 ± 37 Delay between IV and intra-arterial 40 ± 15 −
Note:—IV indicates intravenous; rtPA, recombinant tissue plasminogen activator.
* Plus-minus values are means ± SD (minutes).